- Case-Based Roundtable
- General Dermatology
- Eczema
- Chronic Hand Eczema
- Chronic Spontaneous Urticaria
- Alopecia
- Aesthetics
- Vitiligo
- COVID-19
- Actinic Keratosis
- Precision Medicine and Biologics
- Rare Disease
- Wound Care
- Rosacea
- Psoriasis
- Psoriatic Arthritis
- Atopic Dermatitis
- Melasma
- NP and PA
- Skin Cancer
- Hidradenitis Suppurativa
- Drug Watch
- Pigmentary Disorders
- Acne
- Pediatric Dermatology
- Practice Management
- Prurigo Nodularis
- Buy-and-Bill
Article
ReCell 'skin' widens introduction
Regenerative medicine firm Avita Medical introduced its ReCell Spray-On-Skin at a symposium held at the recent Cosmedica 2011 Congress for Aesthetic & Surgical Medicine held in Bochum, Germany, Medical News Today reports.
Cambridge, England - Regenerative medicine firm Avita Medical, based here, introduced its ReCell Spray-On-Skin at a symposium held at the recent Cosmedica 2011 Congress for Aesthetic & Surgical Medicine held in Bochum, Germany, Medical News Today reports.
The symposium included presentations demonstrating the use of ReCell from its initial introduction for the treatment of severe burns to diverse indications including scar remodeling and treatment of hypo- and hyperpigmentation conditions such as vitiligo.
More than 3,500 patients have been treated with ReCell for treatment of burns, hypo- and hyperpigmentation, scar revisions and aesthetic skin rejuvenation procedures, such as wrinkle removal. Use of ReCell has been clinically demonstrated to improve outcomes, reduce morbidity and reduce length of hospital stay and patient-care costs, Medical News Today reports.
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
